CASI PHARMACEUTICALS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
CASI PHARMACEUTICALS, INC. (CASIF) reported Revenue from Contract with Customer, Excluding Assessed Tax of $28.54 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2025-03-31
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|
| 2024-12-31 | $28.54M 20-F · filed 2025-03-31 |
| 2023-12-31 | $33.88M 20-F · filed 2025-03-31 |
| 2022-12-31 | $38.05M 20-F · filed 2025-03-31 |
| 2021-12-31 | $30.02M 20-F · filed 2024-03-28 |
| 2020-12-31 | $15.00M 20-F · filed 2023-04-26 |